Skip to main content
. 2020 May 6;23(5):e25492. doi: 10.1002/jia2.25492

Table 2.

Factors associated with separate HIV and substance use stigma scores among HIV‐positive PWID receiving OAT at seven sites in Ukraine: linear regression analysis, n = 190 a

  HIV stigma score Substance use stigma score
Crude beta (95% CI) Adjusted beta (95% CI) Crude beta (95% CI) Adjusted beta (95% CI)
Co‐located OAT and ART sites (ref. OAT only sites) 0.25 (−3.16, 3.66) 1.55 (−1.73, 4.84) −0.31 (−4.06, 3.43) 3.14 (−0.15, 6.43)
Demographical characteristics
Age, years 0.02 (−0.23, 0.27) −0.15 (−0.42, 0.12)
Male gender (ref. female) −3.20 (−7.09, 0.69) −1.47 (−5.76, 2.83)
Married/have regular partner (ref. single, never married, divorced, separated or widowed) 0.20 (−3.25, 3.65) −3.38 (−7.13, 0.38)
Household size, persons −0.09 (−1.11, 0.93) 0.52 (−0.60, 1.64)
Living with children under 18 years (ref. no) 1.26 (−2.43, 4.96) 1.01 (−3.05, 5.06)
High school or less (ref. higher education) 1.52 (−3.11, 6.16) 3.26 (−1.82, 8.33)
Vocational (ref. higher education) −0.01 (−4.63, 4.62) 1.29 (−3.77, 6.35)
Unemployed including housewives and students (ref. full or part‐time employment) 1.82 (−1.64, 5.27) 4.22 (0.47, 7.97) 3.14 (−0.20, 6.47)
Personal monthly income above the median: >1667 UAH b (ref. median or below) −3.50 (−6.88, −0.12) −2.51 (−5.85, 0.83) −1.39 (−5.13, 2.36)
History of incarceration (ref. no) −1.90 (−5.52, 1.72) −1.92 (−5.89, 2.06)
Behavioural characteristics
Any illicit drug use during the last 30 days (ref. no) −1.17 (−4.58, 2.24) 3.26 (−0.46, 6.98)
1 sexual partner during the last 12 months (anal/vaginal sex) (ref. no partners) −0.64 (−4.93, 3.65) −1.00 (−5.74, 3.73)
≥2 sexual partners during the last 12 months (anal/vaginal sex) (ref. no partners) 1.47 (−3.94, 6.88) 2.76 (−3.21, 8.73)
Condomless sex during the last 12 months (anal/vaginal) (ref. no) −0.44 (−3.94, 3.06) −0.29 (−4.13, 3.55)
History of selling sex (ref. no) 0.35 (−6.16, 6.87) 0.84 (−6.31, 7.99)
Everyday or occasional smoker (ref. smoked before or never smoked) −3.29 (−10.56, 3.99) 2.56 (−5.43, 10.55)
AUDIT‐C score −0.43 (−1.11, 0.25) 0.40 (−0.35, 1.14)
Clinical characteristics
Time since first HIV‐positive test result, years −0.12 (−0.39, 0.15) −0.09 (−0.39, 0.20)
CD4 count 0.00 (−0.01, 0.00) 0.00 (−0.01, 0.01)
History of TB (ref. no) 1.68 (−2.32, 5.68) −0.63 (−5.03, 3.76)
Diagnosed with HCV (ref. no) 1.65 (−3.84, 7.14) 2.10 (−3.87, 8.07)
SF12v2 physical health T‐score −0.25 (−0.43, −0.07) −0.13 (−0.32, 0.05) −0.17 (−0.38, 0.03)
SF12v2 mental health T‐score −0.27 (−0.44, −0.09) −0.15 (−0.34, 0.03) −0.46 (−0.65, −0.27) −0.26 (−0.44, −0.08)
Ever attempted suicide (ref. no) 7.31 (3.68, 10.93) 5.90 (2.05, 9.75) 8.13 (4.15, 12.10) 2.10 (−1.59, 5.79)
OAT drug: methadone (ref. Buprenorphine) −1.86 (−5.92, 2.20) −0.33 (−4.79, 4.14)
OAT duration, years 0.25 (−0.41, 0.91) 0.00 (−0.72, 0.72)
Attitudes
Perceived accessibility of the healthcare facility −0.02 (−0.10, 0.05) −0.10 (−0.19, −0.02) −0.05 (−0.12, 0.03)
Perceived user‐friendliness of the healthcare facility −0.01 (−0.08, 0.06) −0.06 (−0.13, 0.02)
Social support score −0.10 (−0.18, −0.02) −0.04 (−0.12, 0.04) −0.13 (−0.21, −0.04) −0.02 (−0.10, 0.06)
Receipt of services at non‐governmental organization (ref. no) 1.91 (−1.92, 5.74) −5.79 (−9.93, −1.67) −6.40 (−10.23, −2.57)

Values in bold indicate statistically significant associations.

ART, antiretroviral treatment; AUDIT‐C, The Alcohol Use Disorders Identification Test, short version; CI, confidence interval; HCV, hepatitis C virus; ref., reference category; OAT, opioid agonist treatment; PWID, people who inject drugs; SF12v2, Short Form Health Survey questionnaire, version 2; TB, tuberculosis; UAH, Ukrainian Hryvnias; WHO, World Health Organization.

a

Missing data on HIV and substance use stigma scores was excluded (n = 1).

b

1U.S. dollar = 26 UAH.